Pharmaceuticals, Biotechnology and Life Sciences
USAFDA has given approvals for Merck’s Pifeltro and Delstrigo for certain HIV-1 patients, based on fFindings from the Phase 3 DRIVE-SHIFT Trial, Merck said on Friday in a press release.
LONDON–(BUSINESS WIRE)–#Biotechnology–The global pharyngeal cancer therapeutics market is expected to post a CAGR of over 6% during the period 2019-2023,…
BOSTON–(BUSINESS WIRE)–Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), a biopharmaceutical company focused on developing and commercializing medicines seeking to…
Results from a matching-adjusted indirect comparison (MAIC) suggest that cabozantinib provides two additional months of progression-free survival versus regorafenib in…
Italian biopharmaceutical specialist for nervous diseases solutions, Newron Pharmaceuticals, and it’s partners Meiji Seika Pharma together with Eisai, got approval to produce and sell Equifina tablets in Japan.
Counseling and resources available free-of-charge to local community SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Magellan Health, Inc. (NASDAQ: MGLN) today announced that it will…
European Commission will in about two months decide on the Committee for Medicinal Products for Human Use’s positive opinion, recommending approval of Rhokiinsa in EU, developed by Aerie Pharmaceuticals, for reduction of elevated intraocular pressure in adult patients.
LOS ANGELES–(BUSINESS WIRE)–#biomarkers–In promoting Andrew Aijian to Partner, DeciBio Consulting announces its first addition to the Partnership since its formation.
TEMPE, Ariz.–(BUSINESS WIRE)–INanoBio, a startup developing early stage disease diagnostics by combining semiconductor nanotechnology with biotechnology and machine learning, to…
STRASBOURG, France–(BUSINESS WIRE)–#Defymed—Medical technology company Defymed, specialized in the design and development of innovative medical devices for the delivery…